Status:

RECRUITING

Effects of a Self-management Program for Temporomandibular Myalgia in Subjects With Fibromyalgia: a Single Arm Study

Lead Sponsor:

Jose Edgar Ferrandez Gomez

Conditions:

Temporomandibular Disorder

Fibromyalgia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Fibromyalgia is one of the most prevalent chronic widespread pain entities today. One of the most common problems in patients with fibromyalgia are alterations of the temporomandibular region, present...

Detailed Description

Study design Analytical, prospective experimental study: uncontrolled clinical trial. Population and study sample The study sample will be made up of subjects diagnosed with fibromyalgia who present ...

Eligibility Criteria

Inclusion

  • Adults over 18 years old.
  • Subjects diagnosed with fibromyalgia.
  • Orofacial pain of at least 3 months of evolution (considered chronic, according to IASP).
  • Presence of myalgia, local myalgia, myofascial pain or referred myofascial pain in the temporomandibular region (according to DC/TMD).

Exclusion

  • Internal temporal-romandibular joint disorder with anterior disc displacement, joint pathology (arthritis), facial paralysis (active), mandibular fracture (active), infectious-inflammatory picture of odontogenic origin (active).
  • Pregnancy.
  • Neuropsychiatric pathologies (schizophrenia, bipolarity, cognitive alteration).
  • Subjects receiving any other physiotherapy treatment in the mandibular region.

Key Trial Info

Start Date :

June 16 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT05426655

Start Date

June 16 2022

End Date

March 1 2025

Last Update

October 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fibrofamur

Murcia, Spain